0001214659-20-004864.txt : 20200520
0001214659-20-004864.hdr.sgml : 20200520
20200520171056
ACCESSION NUMBER: 0001214659-20-004864
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200518
FILED AS OF DATE: 20200520
DATE AS OF CHANGE: 20200520
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CARTER BRUCE L A
CENTRAL INDEX KEY: 0001225503
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35921
FILM NUMBER: 20898941
MAIL ADDRESS:
STREET 1: C/O ZYMOGENETICS, INC.
STREET 2: 1201 EASTLAKE AVENUE
CITY: SEATTLE
STATE: WA
ZIP: 98102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mirati Therapeutics, Inc.
CENTRAL INDEX KEY: 0001576263
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 462693615
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9393 TOWNE CENTRE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-332-3410
MAIL ADDRESS:
STREET 1: 9393 TOWNE CENTRE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
marketforms-48830.xml
PRIMARY DOCUMENT
X0306
4
2020-05-18
0001576263
Mirati Therapeutics, Inc.
MRTX
0001225503
CARTER BRUCE L A
C/O MIRATI THERAPEUTICS, INC
9393 TOWNE CENTRE DRIVE, STE 200
SAN DIEGO
CA
92121
true
false
false
false
Common Stock
2020-05-18
4
M
false
4000
6.78
A
6000
D
Common Stock
2020-05-18
4
S
false
4000
106.8601
D
2000
D
Non-Qualified Stock Option (right to buy)
6.78
2020-05-18
4
M
false
4000
0
D
2026-09-26
Common Stock
4000
9000
D
All shares sold at an exact price.
The shares subject to the Option vest and become exercisable in 36 equal monthly installments following the date of grant.
/s/ Vickie Reed, Attorney-in-Fact
2020-05-20